Polymorphisms in the genes encoding the 4 RET ligands, GDNF, NTN, ARTN, PSPN, and susceptibility to Hirschsprung disease

Journal of Pediatric Surgery

Volumn 43, Issue 11, 2008, Pages 2042-2047

  Fernandez, Raquel M ^a   Ruiz Ferrer, Macarena ^a   Lopez Alonso, Manuel ^a   Antiñolo, Guillermo ^a   Borrego, Salud ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Candidate gene; Haplotypes; Hirschsprung; Polygenic disease; Susceptibility factors

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; PROTEIN ARTN; PROTEIN NRTN; PROTEIN PSPN; PROTEIN RET; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HIRSCHSPRUNG DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVOUS SYSTEM DEVELOPMENT; PRIORITY JOURNAL;

ALLELES; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTORS; HAPLOTYPES; HIRSCHSPRUNG DISEASE; HUMANS; MALE; NERVE TISSUE PROTEINS; NEURTURIN; NUCLEAR PROTEINS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SPAIN;

EID: 55649117520     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2008.05.018     Document Type: Article

References (28)

1. Chakravarti A., and Lyonnet S. Hirschsprung disease. In: Scriver C.S. (Ed). The metabolic and molecular bases of inherited disease (2001), McGraw-Hill, New York 6231-6255
2. Badner J.A., Sieber W.K., Garver K.L., et al. A genetic study of Hirschsprung disease. Am J Hum Genet 46 (1990) 568-580
3. Wakamatsu N., Yamada Y., Yamada K., et al. Mutations in SIP1, encoding Smad interacting protein-1, cause a form of Hirschsprung disease. Nat Genet 27 (2001) 369-370
4. Amiel J., Laudier B., Attie-Bitach T., et al. Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome. Nat Genet 33 (2003) 459-461
5. Brooks A.S., Bertoli-Avella A.M., Burzynski G.M., et al. Homozygous nonsense mutations in KIAA1279 are associated with malformations of the central and enteric nervous systems. Am J Hum Genet 77 (2005) 120-126
6. Takahashi M. The GDNF/RET signaling pathway and human diseases. Cytokine Growth Factor Rev 12 (2001) 361-373
7. Ruiz-Ferrer M., Fernandez R.M., Antiñolo G., et al. A complex additive model of inheritance for HSCR is supported by both RET mutations and predisposing RET haplotypes. Genet Med 8 (2006) 704-710
8. Borrego S., Saez M.E., Ruiz A., et al. Specific polymorphisms in the RET proto-oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression. J Med Genet 36 (1999) 771-774
9. Borrego S., Ruiz A., Saez M.E., et al. RET genotypes comprising specific haplotypes of polymorphic variants predispose to isolated Hirschsprung disease. J Med Genet 37 (2000) 572-578
10. Borrego S., Wright F.A., Fernandez R.M., et al. A founding locus within the RET proto-oncogene may account for a large proportion of apparently sporadic Hirschsprung disease and a subset of cases of sporadic medullary thyroid carcinoma. Am J Hum Genet 72 (2003) 88-100
11. Burzynski G.M., Nolte I.M., Bronda A., et al. Identifying candidate Hirschsprung disease-associated RET variants. Am J Hum Genet 76 (2005) 850-858
12. Fernandez R.M., Boru G., Peciña A., et al. Ancestral RET haplotype associated with Hirschsprung's disease shows linkage disequilibrium breakpoint at -1249. J Med Genet 42 (2005) 322-327
13. Garcia-Barcelo M., Ganster R.W., Lui V.C., et al. TTF-1 and RET promoter SNPs: regulation of RET transcription in Hirschsprung's disease. Hum Mol Genet 14 (2005) 191-204
14. Griseri P., Bachetti T., Puppo F., et al. A common haplotype at the 5¢ end of the RET proto-oncogene, overrepresented in Hirschsprung patients, is associated with reduced gene expression. Hum Mutat 25 (2005) 189-195
15. Pelet A., de Pontual L., Clement-Ziza M., et al. Homozygosity for a frequent and weakly penetrant predisposing allele at the RET locus in sporadic Hirschsprung disease. J Med Genet 42 (2005) e18
16. Emison E.S., McCallion A.S., Kashuk C.S., et al. A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk. Nature 434 (2005) 857-863
17. Airaksinen M.S., and Saarma M. The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci 3 (2002) 383-394
18. Bolk S., Pelet A., Hofstra R.M., et al. A human model for multigenic inheritance: phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus. Proc Natl Acad Sci U S A 97 (2000) 268-273
19. Gabriel S.B., Salomon R., Pelet A., et al. Segregation at three loci explains familial and population risk in Hirschsprung disease. Nat Genet 31 (2002) 89-93
20. Dracapoli N.H., Haines J.L., and Korf B.R. Current protocols in human genetics (1994), John Wiley and Sons, New York
21. Cebrian A., Lesueur F., Martin S., et al. Polymorphisms in the initiators of RET (rearranged during transfection) signaling pathway and susceptibility to sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 90 (2005) 6268-6274
22. McCallion A.S., Emison E.S., Kashuk C.S., et al. Genomic variation in multigenic traits: Hirschsprung disease. Cold Spring Harb Symp Quant Biol 68 (2003) 373-381
23. Borrego S., Fernandez R.M., Dziema H., et al. Investigation of germline GFRA4 mutations and evaluation of the involvement of GFRA1, GFRA2, GFRA3, and GFRA4 sequence variants in Hirschsprung disease. J Med Genet 40 (2003) e18
24. Myers S.M., Salomon R., Goessling A., et al. Investigation of germline GFR alpha-1 mutations in Hirschsprung disease. J Med Genet 36 (1999) 217-220
25. Onochie C.I., Korngut L.M., Vanhorne J.B., et al. Characterisation of the human GFRalpha-3 locus and investigation of the gene in Hirschsprung disease. J Med Genet 37 (2000) 674-679
26. Vanhorne J.B., Gimm O., Myers S.M., et al. Cloning and characterization of the human GFRA2 locus and investigation of the gene in Hirschsprung disease. Hum Genet 108 (2001) 409-415
27. Salomon R., Attié T., Pelet A., et al. Germline mutations of the RET ligand GDNF are not sufficient to cause Hirschsprung disease. Nat Genet 14 (1996) 345-347
28. Doray B., Salomon R., Amiel J., et al. Mutation of the RET ligand, neurturin, supports multigenic inheritance in Hirschsprung disease. Hum Mol Genet 7 (1998) 1449-1452